Heart disease and cancer were again the leading causes of death in the U.S. in 2024, according to a CDC report published Sept. 10, which analyzed 99.9% of 2024 death records as of June 1, 2025. At the same time, the overall death rate decreased by 3.8% to the lowest it’s been since 2020, from […]
Heart Disease, Cancer Deaths Increased in 2024: CDC Read More »
You are unauthorized to view this page. Username Password Remember Me Forgot Password
Heart Disease, Cancer Deaths Increased in 2024: CDC Read More »
Private equity (PE) acquisitions of physician practices have seen a significant increase in recent years. The surge in PE acquisitions raises concerns about market consolidation, affordability, and quality of care, particularly for disadvantaged patients. This study examines the trend of PE acquisitions in oncology from 2013 to 2022, quantifying market shares, analyzing changes in price
Private Equity Acquisitions in Oncology: Impact on Market Share and Prices Read More »
You are unauthorized to view this page.
Private Equity Acquisitions in Oncology: Impact on Market Share and Prices Read More »
Conway Hematology Oncology (CHO), a trusted provider of hematology and oncology care in Conway, Arkansas, is proud to announce it has joined American Oncology Network (AON), one of the nation’s fastest-growing networks of community-based oncology practices. This partnership enables CHO to expand patient-focused services, grow clinical trial offerings, and pursue new market opportunities—while continuing to
You are unauthorized to view this page.
OneOncology, a physician-led national platform supporting independent oncology practices, and its Monterey-based partner Pacific Cancer Care, announce they have signed definitive agreements to acquire the radiation oncology clinic located at 15400 National Ave., Suite 100 in Los Gatos from Good Samaritan Hospital. This acquisition ensures continued patient access to the region’s only community-based radiation treatment
You are unauthorized to view this page.
Strategic Consolidation in Oncology Read More »
Three companies—McKesson, Cencora, and Cardinal Health—account for over 90% of the wholesale drug distribution market in the United States. Since 2019, U.S. spending on oncology drugs has risen from approximately $65 billion to $99 billion in 2023, representing nearly 45% of global oncology drug spending. In 2023, U.S. pharmaceutical expenditures reached $722.5 billion, with oncology
Strategic Consolidation in Oncology Read More »
